U.S. pharma big copyright scrapped two experimental weight loss capsules last yr—a as soon as-daily tablet, lotiglipron, resulting from elevated liver enzymes along with a two times-day-to-day tablet, danuglipron, as a result of robust Uncomfortable side effects—but CEO Albert Bourla has said the company is determined to “Engage in and earn�